Paper - WANFANG MED ONLINE

You Position: Home > Paper

Neoadjuvant therapy in gastric cancer: Current status and future perspectives

( views:32, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 33

DOI:: 10.11569/wcjd.v26.i33.1939

Key Word:: 进展期胃癌;胃癌;新辅助放疗;新辅助化疗;新辅助放化疗

Abstract：胃癌在我国发病率较高,预后较差.多数患者确诊时已处于局部进展期,单纯手术治疗局部复发率高,生存状况较差,因此新辅助治疗受到关注.目前相关临床研究显示新辅助治疗使进展期患者获得临床受益,而有关新辅助治疗的最佳方式以及新辅助放化疗和新辅化疗的疗效比较仍需要更多前瞻性临床研究数据.

Reference

[1]Roberto Biffi,Nicola Fazio,Fabrizio Luca,etc.Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer[J].2010,(7).
[2]I Songun,H.J Keizer,J Hermans,etc.Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial[J].1999,35(4).
[3]Becker K,Langer R,Reim D,etc.Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.[J].2011,253(5).
[4]I B, Shchepotin,S R, Evans,V, Chorny,etc.Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma.[J].1994,3(1).
[5]Morel P,Zwahlen D,Roth AD,etc.Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial.[J].2005,63(5).
[6]P, Rougier,P, Lasser,M, Ducreux,etc.Preoperative chemotherapy of locally advanced gastric cancer.[J].1994,5.
[7]江良县,周申康,刘帅,等.新辅助化疗联合腹腔镜手术治疗进展期胃癌效果及患者生活质量情况观察[J].2018,(13).
[8]Cunningham D,Allum WH,Stenning SP,etc.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.[J].2006,355(1).
[9]Smyth, E. C.,Verheij, M.,Allum, W.,etc.Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].2016,27(Suppl.5).
[10]Peter Crookes,Cynthia Gail Leichman,Lawrence Leichman,etc.Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: A final report[J].1997,79(9).
[11]Skoropad V,Berdov B,Zagrebin V.Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial.[J].2002,80(2).
[12]Stahl, Michael,Walz, Martin K.,Riera-Knorrenschild, Jorge,etc.Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial[J].2017,81.
[13]J A, Ajani,R J, Mayer,D M, Ota,etc.Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.[J].1993,85.
[14]Persiani R,Biondi A,Boccia S,etc.Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.[J].2006,32(10).
[15]Pisters PW,Janjan N,Crane CH,etc.Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.[J].2005,23(6).
[16]VanHagen,P.,Hulshof,M.C.C.M.,VanLanschot,J.J.B.,etc.Preoperative chemoradiotherapy for esophageal or junctional cancer[J].2012,366(22).
[17]Zhi-Xian Zhang,Xian-Zhi Gu,Wei-Bo Yin,etc.Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients[J].1998,42(5).
[18]Lynch PM,Mansfield PF,Feig B,etc.Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.[J].2004,22(14).
[19]Gunderson LL,Smalley SR,Hundahl SA,etc.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.[J].2001,345(10).
[20]Pisters PW,Janjan N,Lowy AM,etc.A pilot study of preoperative chemoradiotherapy for resectable gastric cancer.[J].2001,8(6).
[21].Japanese classification of gastric carcinoma: 3rd English edition.[J].2011,14(2).
[22]Patrick Therasse,Susan G. Arbuck,Elizabeth A. Eisenhauer,etc.New Guidelines to Evaluate the Response to Treatment in Solid Tumors[J].2000,92(3).
[23]Donohue JH,Okawara GS,Ajani JA,etc.Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.[J].2006,24(24).